Back to Browse Journals » International Journal of Nanomedicine » Volume 2 » Issue 2

Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes

Authors Massimo Bottini, Federica D’Annibale, Andrea Magrini, Fabio Cerignoli, Yutaka Arimura, Marcia I Dawson, Enrico Bergamaschi, Nicola Rosato, Antonio Bergamaschi, Tomas Mustelin

Published Date August 2007 Volume 2007:2(2) Pages 227—233


Published 16 August 2007

Massimo Bottini1,2,4, Federica D’Annibale2, Andrea Magrini2, Fabio Cerignoli1, Yutaka Arimura1, Marcia I Dawson1, Enrico Bergamaschi5, Nicola Rosato3, Antonio Bergamaschi1, Tomas Mustelin1

1Burnham Institute for Medical Research, La Jolla, CA, USA; 2NAST and Department of Environmental, Occupational and Social Medicine, University of Rome Tor Vergata, Rome, Italy; 3NAST and Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Rome, Italy; 4INFN, Laboratori Nazionali di Frascati, Frascati, Italy; 5Department of Clinical Medicine, Nephrology and Health Sciences, University of Parma, Parma, Italy

Abstract: To enhance diagnostic or therapeutic efficacy, novel nanomaterials must be engineered to function in biologically relevant environments, be visible by conventional fluorescent microscopy, and have multivalent loading capacity for easy detection or effective drug delivery. Here we report the fabrication of silica nanoparticles doped with quantum dots and superficially functionalized with amino and phosphonate groups. The amino groups were acylated with a water-soluble biotin-labeling reagent. The biotinylated nanoparticles were subsequently decorated with neutravidin by exploiting the strong affinity between neutravidin and biotin. The resultant neutravidin-decorated fluorescent silica nanoparticles stably dispersed under physiological conditions, were visible by conventional optical and confocal fluorescent microscopy, and could be further functionalized with macromolecules, nucleic acids, and polymers. We also coated the surface of the nanoparticles with biotinylated mouse anti-human CD3 (αCD3). The resultant fluorescent nanoassembly was taken up by Jurkat T cells through receptor-mediated endocytosis and was partially released to lysosomes. Thus, quantum dotdoped silica nanoparticles decorated with neutravidin represent a potentially excellent scaffold for constructing specific intracellular nanoprobes and transporters.

Keywords: silica nanoparticles, neutravidin, surface functionalization, endocytosis, intracellular nanoprobe

Download Article [PDF] 

Readers of this article also read:

Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia

Douglas L Noordsy, Glenn A Phillips, Daniel E Ball, et al

Patient Preference and Adherence 2010, 4:263-271

Published Date: 20 July 2010

Laser-fabricated castor oil-capped silver nanoparticles

Reza Zamiri, Azmi Zakaria, Hossein Abbastabar, et al

International Journal of Nanomedicine 2011, 6:565-568

Published Date: 23 March 2011

Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting

Xie F, Yao N, Qin Y, Zhang Q, Chen H, Yuan M, Tang J, Li X, Fan W, Zhang Q, Wu Y, Hai L, He Q

International Journal of Nanomedicine 2012, 7:163-175

Published Date: 6 January 2012

Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles

Sabnis N, Nair M, Israel M, McConathy WJ, Lacko AG

International Journal of Nanomedicine 2012, 7:975-983

Published Date: 22 February 2012

Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles

Lellouche J, Friedman A, Lahmi R, Gedanken A, Banin E

International Journal of Nanomedicine 2012, 7:1175-1188

Published Date: 1 March 2012

Concentration-dependent effects of fullerenol on cultured hippocampal neuron viability

Zha YY, Yang B, Tang ML, Guo QC, Chen JT, Wen LP, Wang M

International Journal of Nanomedicine 2012, 7:3099-3109

Published Date: 29 June 2012

Lebrikizumab in the personalized management of asthma

Thomson NC, Patel M, Smith AD

Biologics: Targets and Therapy 2012, 6:329-335

Published Date: 14 September 2012